ICTUImperial Clinical Trials Unit

Welcome to Imperial Clinical Trials Unit (ICTU)

This website is intended for commercial trial sponsors engaged in the area of pharmaceuticals, medical devices or diagnostic devices

Clinical Trials Search

OR

CurrentAll Trials

ENDOBARRIER

Trial Details

EndoBarrier TM Gastrointestinal Liner Diabetes Trial

Design and Objective

A new device called the EndoBarrier Gastrointestinal Liner helps patients with diabetes manage their blood sugar levels and lose weight without the need for surgery. This study compares how effective the EndoBarrier device is compared to standard medical care in the treatment of type 2 diabetes mellitus.

Key inclusion criteria

If you are aged 18-65 years, living with Type 2 Diabetes and have a BMI between 30-50kg/m2, you may be eligible.

Support Documents/Links

Study Disclaimer Statement